92.   Alejaldre, L., Pelletier, J. N., & Quaglia, D. (2021). Title: Methods for enzyme library creation: Which one will you choose? BioEssays, 43, e2100052. https://doi.org/10.1002/bies.202100052

91.   Valikhani, D,. Bolivar, J. M.,  Pelletier, J. N. An Overview of Cytochrome P450 Immobilization Strategies for Drug Metabolism Studies, Biosensing, and Biocatalytic Applications: Challenges and Opportunities. ACS Catalysis 2021 11 (15), 9418-9434 DOI: 10.1021/acscatal.1c02017 10.1038/s41598-021-00844-z.

90.   Jodaylami, M.H., Djaileb, A., Ricard, P., Lavallée, E., Cellier-Goetghebeur, S., Parker, M.-F., Coutu, J., Stuible, M., Gervais, C., Durocher, Y., Cayer, M.-P., De Grandmont, M.J., Rochette, S., Brouard, D., Trottier, S., Boudreau, D., Pelletier, J.N., Masson, J.-F. (2021): Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins. Nature Scientific Reports. doi: 10.1038/s41598-021-00844-z.

89.    Djaileb, A., Hojjat Jodaylami, M., Coutu J, Ricard, P., Lamarre, M., Rochet, L., Cellier-Goetghebeur, S., Macaulay, D., Charron, B., Lavallée, É., Thibault, V., Stevenson, K., Forest, S., Live, LS., Abonnenc, N., Guedon, A., Quessy, P., Lemay, JF., Farnós, O., Kamen, A., Stuible, M., Gervais, C., Durocher, Y., Cholette, F., Mesa, C., Kim, J., Cayer, MP., de Grandmont, MJ., Brouard, D., Trottier, S., Boudreau, D., Pelletier, JN., Masson, JF. Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals. Analyst. 2021 Jul 26;146(15):4905-4917. doi: 10.1039/d1an00893e. PMID: 34250530. 

88.    Lemay-St-Denis, C., Diwan, S. S., Pelletier, J.N. (2021): The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights An Emerging Threat to Public Health. Antibiotics. https://www.mdpi.com/2079-6382/10/4/433

87.     Paquet-Côté, P.-A., Alejaldre, L., Verreault, C. L., Gobeil S.M.C., Lamoureux, R., Bédard, L., Normandeau, C.-O., Lemay-St-Denis, C., Pelletier, J.N., Voyer, N. (2021) Development of sulfahydantoin derivatives as β-lactamase inhibitors. Bioorganic & Medicinal Chemistry Letters https://www.sciencedirect.com/science/article/pii/S0960894X2100007X

86.     Djaileb, A., Charron, B., Jodaylami, M. H., Thibault V., Coutu, J., Stevenson, K., Forest, S., Live,  L. S., Boudreau, D., Pelletier, J.N., Masson, J.-F. (2020): A Rapid and Quantitative Serum Test for SARS-CoV-2 Antibodies with Portable Surface Plasmon Resonance Sensing. ChemRxiv. Preprint. https://doi.org/10.26434/chemrxiv.12118914.v1

85.   Alejaldre, L., Lemay-St-Denis, C., Perez, C., Sancho Jodar, F., Guallar, V. and Pelletier, J.N. Known evolutionary paths are accessible to engineered ß-lactamases having altered protein motions at the timescale of catalytic turnover. Frontiers (in press).

84.   Deweid, L.*, H.-Parisien, A.*, Lafontaine, K., Rochet, L.N.C., Kolmar, H. and Pelletier, J.N. (2020) Glutamine-walking: creating reactive substrates for transglutaminase-mediated protein labelling. Met. Enzymol., 644:121-148. (*equal contribution)

83.    Rousseau, O., Ebert, M.C., Quaglia, D., Fendri, A., H.-Parisien, A., Besna, J. N., Iyathurai, S. and Pelletier, J.N. (2019) Indigo Formation and Rapid NADPH Consumption Provide Robust Prediction of Raspberry Ketone Synthesis by Engineered Cytochrome P450 BM3. ChemCatChem, 12(3): 837-845.

82.   Toulouse, J., Yachnin, B., Ruediger, E., Deon, D., Gagnon, M., Saint-Jacques, K., Ebert, M., Forge, D., Bastien, D., Colin, D., Vanden Eynde, J.-J., Marinier, A., Berghuis, A. and Pelletier, J.N. (2019) Structure-based design of dimeric bisbenzimidazole inhibitors to an emergent trimethoprim-resistant type II dihydrofolate reductase guide the design of monomeric analogs. ACS Omega, 4(6):10056-10069.

81.    Gobeil, S. M., Ebert, M. C., Park, J., Gagné, D., Doucet, N., Berghuis, A. M. & Pelletier, J. N. (2019). the structural Dynamics of engineered β-Lactamases Vary Broadly on three timescales yet sustain Native Function. Scientific reports, 9(1), 6656.

80.    Quaglia, D., Alejaldre, L., Ouadhi, S., Rousseau, O., Pelletier, J.N. (2019) Holistic engineering of Cal-A lipase chain-length selectivity identifies triglyceride binding spot. PLOS One, 14 (1), e0210100.

79.    Charbonneau, D., Breault-Turcot, J., Sinnett, D., Krajinovic, M., Leclerc, J-M, Masson, J-F., Pelletier, J. N. (2017). Tracking silent hypersensitivity reactions to asparaginase during leukemia therapy using single-chip indirect plasmonic and fluorescence immunosensing. ACS Sensors. In press

78.    Rachel, N. M., Toulouse, J. L. and Pelletier, J. N. (2017) Transglutaminase-Catalyzed Bioconjugation Using One-Pot Metal-Free Bioorthogonal Chemistry. ACS Bioconjugate Chemistry, 28(10), 2518-2523.

77.    Rachel, N. M., Quaglia, D., Lévesque, E., Charette, A. B. and Pelletier, J. N. (2017) Engineered, highly reactive substrates of microbial transglutaminase enable protein labeling within various secondary structure elements. Protein Science, 26(11), 2268-2279.

76.    Ebert, M.C.C.J.C., Guzman Espinola, J., Lamoureux, G. and Pelletier, J. N. (2017) Substrate-specific screening for mutational hotspots using biased molecular dynamics simulations. ACS Catalysis, 7(10), 6786–6797.

75.    Charbonneau, D. M., Aubé, A., Rachel. N. M., Guerrero, V., Delorme, K., Breault-Turcot, J., Masson, J.-F. and Pelletier, J. N. (2017) Development of E. coli asparaginase II for immunosensing: A trade-off between receptor density and sensing efficiency. ACS Omega, 2(5), 2114–2125

74.    Lévesque, É., Bechara, W., Constantineau-Forget, L., Pelletier, G., Rachel, N. M., Pelletier, J. N. and Charette, A. B. (2017) General C–H Arylation Strategy for the Synthesis of Tunable Visible Light Emitting High Stokes Shift Benzo[a]imidazo[2,1,5-c,d]indolizine Fluorophores. Journal of Organic Chemistry, p.5046-5067.

73.    Toulouse, J. L., Abraham, S. M. J., Kadnikova, N., Bastien, D., Gauchot, V., Schmitzer. A. R., and Pelletier, J. N. (2017) Investigation of classical organic and ionic liquid co-solvents for early stage screening in fragment-based inhibitor design with unrelated bacterial and human dihydrofolate reductases. Assay and Drug Development Technologies, p.141-153.

72.    Toulouse, J. L. , Edens, T. J., Alejaldre, L., Manges, A. R. and Pelletier, J. N. (2017) Integron-Associated DfrB4, a Previously Uncharacterized Member of the Trimethoprim-Resistant Dihydrofolate Reductase B Family, Is a Clinically Identified Emergent Source of Antibiotic Resistance. Antimicrobial Agents and Chemotherapy 61 (5) e02665-16.

71.    Quaglia, D., Ebert, M. C. C. J. C., Mugford,P. F. and Pelletier, J. N. (2017) Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening. PloS One http://dx.doi.org/10.1371/journal.pone.0171741.

70.    Ebert, M. C. C. J. C. and Pelletier, J. N. (2017) Computational tools for enzyme improvement: why everyone can – and should – use them. Curr. Opin. Chem. Biol., 37, 89–96.

69.    Aubé, A., Charbonneau, D., Pelletier, J. N. and Masson, J.-F. (2016) Response monitoring of acute lymphoblastic leukemia (ALL) patients undergoing L-asparaginase therapy: Successes and challenges associated with clinical sample analysis in plasmonic sensing. ACS Sensors 1, 1358−1365.

68.    Ebert, M. C. C. J. C., Dürr, S. L., Houle, A. A., Lamoureux, G. and Pelletier, J. N. (2016) Evolution of P450 Monooxygenases toward Formation of Transient Channels and Exclusion of Nonproductive Gases. ACS Catal. 6, 7426−7437.

67.    Rachel, N. M. and Pelletier, J. N. (2016) One-Pot Peptide and Protein Conjugation: Combination of Enzymatic Transamidation and Click Chemistry. Chemical Communications, 52, 2541 – 2544.

66.    St-Jacques, A. D., Rachel, N. M., Curry, D. R., Gillet, S. M. F. G., Clouthier, C. M., Keillor, J. W., Pelletier, J. N. and Chica, R. A. (2016) Specificity of Transglutaminase-Catalyzed Peptide Synthesis. J. Mol. Catal. B: Enzymatic, 123: 53–61. doi:10.1016/j.molcatb.2015.11.009.

65.    Gobeil, S. M. C., Gagné, D., Doucet, N. and Pelletier, J. N. (2016) 15N, 13C and 1H backbone resonance assignments of an artificially engineered TEM-1/PSE-4 class A β-lactamase chimera and its deconvoluted mutant. Biomol NMR Assign, doi:10.​1007/​s12104-015-9645-8.

64.    Yockell-Lelièvre, H., Bukar, N., Toulouse, J. L., Pelletier, J. N. and Masson, J.-F. (2016) Naked-eye nanobiosensor for therapeutic drug monitoring of methotrexate. Analyst, 141, 697 – 703.

63.    Editorial: Masson JF, Pelletier JN. (2015) Will nanobiosensors change therapeutic drug monitoring? The case of methotrexate. Nanomedicine(lond.). 10(4), 521-524.

62.    Invited article: Ebert MC, Morley KL, Volpato JP, Schmitzer AR, Pelletier JN. (2015) Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active-site substitutions. Protein Sci. vol 24, 495-507.

61.    Zhao SS, Bukar N, Toulouse JL, Pelechacz D, Robitaille R, Pelletier JN, Masson JF. (2014) Miniature multi-channel SPR instrument for methotrexate monitoring in clinical samples. Biosens. Bioelectron. 64, 664-670.

60.    Gobeil SM, Clouthier CM, Park J, Gagné D, Berghuis AM, Doucet N, Pelletier JN. (2014) Maintenance of native-like protein dynamic may not be required for engineering functional proteins. Chem Biol. 21(10), 1330-1340 Article previewed in: Tokuriki N, Jackson CJ (2014) Enzyme dynamics and engineering: one step at a time, Chem Biol. 21(10), 1259-1260.

59.    Gundersen MT, Keillor JW, Pelletier JN. (2014) Microbial transglutaminase displays broad acyl-acceptor substrate specificity.Appl Microbiol Biotechnol 98:219–230.

58.    Bukar N, Zhao SS, Charbonneau DM, Pelletier JN, Masson JF. (2014) Influence of the Debye length on the interaction of small molecule-modified nanoparticle with a surface-bound bioreceptor. Chem Commun (Camb). 18;50(38) 4947-4950.

57.    Aubé A, Breault-Turcot J, Chaurand P, Pelletier JN, Masson JF. (2013) Non-specific adsorption of crude cell lysate on surface plasmon resonance sensors. Langmuir. 2013 Aug 13;29(32):10141-8. doi: 10.1021/la401837y.

56.    Ratel M, Provencher-Girard A, Zhao SS, Breault-Turcot J, Labrecque-Carbonneau J, Branca M, Pelletier JN, Schmitzer AR, Masson JF. (2013) Imidazolium-based ionic liquid surfaces for biosensing. Anal Chem. 2013 Jun 18;85(12):5770-7. doi: 10.1021/ac400386z.

55.    Rachel NM, Pelletier JN. (2013) Biotechnological Applications of Transglutaminases. Biomolecules 2013, 3, 870-888. doi:10.3390/biom3040870.

54.    Clouthier CM, Morin S, Gobeil SM, Doucet N, Blanchet J, Nguyen E, Gagné SM, Pelletier JN. (2012) Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions. PLoS One. 2012;7(12):e52283.

53.    Zhao, S. S., Bichelberger, M. A., Colin, D. Y., Robitaille, R., Pelletier, J. N., and Masson, J. F. (2012) Monitoring methotrexate in clinical samples of cancer patients during chemotherapy with a LSPR-based competitive sensor. Analyst 2012, 137, 4742-4750.

52.    Gnaccarini, C., Ben-Tahar, W., Mulani, A., Roy, I., Lubell, W. D., Pelletier, J. N. and Keillor, J. W. Site-Specific Protein Propargylation Using Tissue Transglutaminase (2012) Org. Biomol. Chem. DOI: 10.1039/C2OB25752A.

51.    Bastien, D., Ebert, M. C. C. J. C., Forge,D., Toulouse, J., Kadnikova, N., Perron, F., Mayence, A., Huang, T. L., Vanden Eynde, J. J., and Pelletier, J. N. (2012) Fragment-Based Design of Symmetrical Bis-benzimidazoles as Selective Inhibitors of the Trimethoprim-Resistant, Type II R67 Dihydrofolate Reductase. J. Med. Chem. 55, 3182-3192.

50.    Clouthier, C. M., and Pelletier, J.N. (2012) Expanding the organic toolbox: a guide to integrating biocatalysis in synthesis. Chem. Soc. Rev. 41, 1585–1605.

49.    Yachnin, B. J.; Colin, D. Y.; Volpato, J. P.; Ebert, M.; Pelletier, J. N.; Berghuis, A. M. (2011) Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 67, 1316-1322.

48.    Bolduc, O. R., Lambert-Lanteigne, P., Colin, D.P., Shuo Zhao, S., Proulx, C., Boeglin, D., Lubell, W., Pelletier, J. N., Féthière, J., Ong, H. and Masson, J.-F. (2011) Peptidomimetic monolayer binding His-tagged biomolecules for small ligand screening with SPR biosensors. Analyst, 136, 3142-3148.

47.    Tang, M-C., Nisole, A., Dupont, C., Pelletier, J.N. and Waldron, K.C. (2011) Chemical profiling of the deacetylase activity of acetyl xylan esterase A (AxeA) variants on chitooligosaccharides using hydrophilic interaction chromatography-mass spectrometry. J. Biotechnol. 155 257– 265

46.    Volpato J.P., Mayotte N., Fossati E., Guerrero V., Sauvageau G., Pelletier J.N. (2011) Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells. J Mol Recognit., 24 (2):188-98.

45.    Banka S., Blom H.J., Walter J., Aziz M., Urquhart J., Clouthier C.M., Rice G.I., de Brouwer A.P., Hilton E., Vassallo G., Will A., Smith D.E., Smulders Y.M., Wevers R.A., Steinfeld R., Heales S., Crow Y.J., Pelletier J.N., Jones S., Newman W.G. (2011) Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet., 88 (2):216-25.

44.    Morin S., Clouthier C.M., Gobeil S., Pelletier J.N., Gagné S.M. (2010) Backbone resonance assignments of an artificially engineered TEM-1/PSE-4 Class A beta-lactamase chimera. Biomol NMR Assign., 4 (2):127-30

43.    Bolduc O.R., Pelletier J.N., Masson J.F. (2010) SPR Biosensing in Crude Serum Using Ultralow Fouling Binary Patterned Peptide SAM. Anal Chem., 82 (9):3699-706.

42.    Doucet, N., and Pelletier, J. N. (2009) Gaining insight into enzyme function through correlation with protein motions. In: Protein Engineering Handbook. S. Lutz, and U. Bornscheuer, eds., Wiley-VCH, Weinheim pp187-211.

41.    Gnaccarini C., Ben-Tahar W., Lubell W.D., Pelletier J.N., Keillor J.W. (2009) Fluorometric assay for tissue transglutaminase-mediated transamidation activity. Bioorg Med Chem., 17 (17): 6354-9.

40.    Bolduc O.R., Clouthier C.M., Pelletier J.N., Masson J.F. (2009) Peptide self-assembled monolayers for label-free and unamplified surface plasmon resonance biosensing in crude cell lysate. Anal Chem., 81 (16): 6779-88.

39.    Volpato J.P., Yachnin B.J., Blanchet J., Guerrero V., Poulin L., Fossati E., Berghuis A.M., Pelletier J.N. (2009) Multiple conformers in active site of human dihydrofolate reductase F31R/Q35E double mutant suggest structural basis for methotrexate resistance. J Biol Chem, 284 (30): 20079-89.

38.    Pardin C., Roy I., Chica R.A., Bonneil E., Thibault P., Lubell W.D., Pelletier J.N., Keillor J.W. (2009) Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors. Biochemistry 48 (15): 3346-53.

37.    Volpato J. P., and Pelletier J.N. (2009) Sequence and structural comparison of mammalian, bacterial and parasitic dihydrofolate reductases: cross-species mutational ‘hot-spots’ provide antifolate resistance. Drug Resistance Updates, 12 (1-2): 28-41.

36.    De Wals P.-Y., Doucet N. and Pelletier J.N. (2009) High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition. Protein Science, 18 (1): 147-160.

35.    Fossati, E. Volpato, J. P., Poulin, L., Guerrero, V., Dugas, D. A. et Pelletier, J. N. (2008) Two-tier in vivo and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate   reductase. Journal of Biomolecular Screening, 13(6) 504-514.

34.    Pardin, C., Pelletier, J. N., Keillor, J. W. and Lubell, W. D. (2008) Cinnamoyl inhibitors of tissue transglutaminase. Journal of Organic Chemistry, 73, 5766-5775.

33.    Keillor, J. W., Chica, R. A., Chabot, N., Vinci, V., Pardin, C., Fortin, E., Gillet, S.M.F.G., Nakano, Y., Kaartinen, M., Pelletier, J. N. and Lubell, W.D. (2008) The Bioorganic Chemistry of Transglutaminase: From Mechanism to Inhibition and Engineering. Canadian Journal of Chemistry,86, 271-276.

32.    Pelletier, J.N., De Wals, P.-Y., Doucet, N. and Volpato, J.P. (2007) Modifying enzyme specificity by combinatorial active site mutations. In: Molecular Interactions: Bringing Chemistry to Life. The 2006 Proceedings of the International Beilstein Workshop. M. Hicks & C. Kettners, eds. pp 59 – 76.

31.    M. Denault and J. N. Pelletier "Protein library design and screening: Working out the probabilities". Methods in Molecular Biology: Protein Engineering Protocols., Humana Press (2007)

*EXCEL SPREADSHEETS

30.    J. Volpato, E. Fossati and J. N. Pelletier "Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase." J. Mol. Biol., 373, 599-611 (2007)

29.    N. Doucet and J. N. Pelletier "Simulated annealing exploration of an active-site tyrosine in TEM-1 ß-lactamase suggests the existence of alternate conformations." Proteins, 69, 340-348 (2007)

28.    N. Doucet, P.-Y. Savard, J. N. Pelletier and S. M. Gagné "NMR investigation of Tyr-105 mutants in TEM-1 ß-lactamase: Dynamics are correlated with function." J. Biol. Chem., 282, 21448-21459 (2007)

27.    J. N. Pelletier and Robert Lortie "Sequence activity relationships guide directed evolution" Nat. Biotechnol., 25, 297-298 (2007)

26.    J. Puglia, T. Wang, C. Smith-Snyder, M. Cote, M. Scher, J. N. Pelletier, S. John, C. B. Jonsson and M. J. Roth. "Revealing Domain Structure through Linker-Scanning Analysis of the Murine Leukemia Virus (MuLV) RNase H and MuLV and Human Immunodeficiency Virus Type 1 Integrase Proteins." J. Virol., 80, 9497-9510 (2006)

25.    A. Nisole, F.-X. Lussier, K. L. Morley, F. Shareck, R. J. Kazlauskas, C. Dupont and J. N. Pelletier. "Extracellular Production of Streptomyces lividans Acetyl-xylan Esterase A in Escherichia coli for Rapid Detection of Activity." Protein Expr. Purif., 46, 274-284 (2006)

24.    S. M. F. G. Gillet, J. N. Pelletier and J. W. Keillor. "A Direct Fluorometric Assay for Tissue Transglutaminase." Anal. Biochem., 347, 221-226 (2005)

23.    R. A. Chica*, N. Doucet* and J. N. Pelletier. "Engineering enzyme activity by semi-rational approaches: combining the benefits of directed evolution and rational design." Curr. Opin. Biotechnol., 16, 378-384 (2005) (*Equal contribution)

22.    L. Berrou, Y. Dodier, A. Raybaud, A. Tousignant, O. Dafi, J. N. Pelletier and L. Parent. "The C-terminal Residues in the Alpha-interacting Domain (AID) Helix Anchor CaV {beta} Subunit Interaction and Modulation of CaV2.3 Channels." J. Biol. Chem., 280, 494-505 (2005)

21.    A.R. Schmitzer, F. Lépine and J. N. Pelletier. "Combinatorial exploration of the catalytic site of a drug-resistant dihydrofolate reductase: creating alternative functional configurations." Protein Eng. Des. Sel., 11, 17, 809-819 (2004)

20.    N. Doucet, P.-Y. De Wals and J. N. Pelletier. "Site-saturation mutagenesis of Tyr105 reveals its importance in substrate stabilization and discrimination in TEM-1 ß-lactamase." J. Biol. Chem., 279, 46295-46303 (2004)

19.    A. Tousignant and J. N. Pelletier. "Protein motions promote catalysis." Chemistry & Biology, 11, 1037-1042 (2004)

18.    R. A. Chica, P. Gagnon, J. W. Keillor and J. N. Pelletier. "Tissue transglutaminase acylation: Proposed role of conserved active site Tyr and Trp residues revealed by molecular modelling of peptide substrate binding." Protein Science, 13, 979-991 (2004)

17.    S. M. F. G. Gillet, R. A. Chica, J. W. Keillor and J. N. Pelletier. "Expression and rapid purification of highly active hexahistidine-tagged guinea pig liver transglutaminase." Protein Expr. Purif., 33, 256-264 (2004)

16.    K. M. Arndt, J. N. Pelletier, K. M. Muller, A. Pluckthun and T. Alber. "Comparison of In Vivo Selection and Rational Design of Heterodimeric Coiled Coils." Structure 10, 1235-1248 (2002)

15.    P. Amstutz, J. N. Pelletier, A. Guggisberg, L. Jermutus, S. Cesaro-Tadic, C. Zahnd and A. Plückthun. "In vitro selection for catalytic activity with ribosome display." J. Am. Chem. Soc. 124(32), 9396-403 (2002)

14.    Remy, J. N. Pelletier, A. Galarneau and S. W. Michnick. "Dynamic visualisation and library screening of protein interactions in living cells with protein fragment complementation strategies". Protein-protein interactions: A molecular cloning laboratory manual, J. Sambrook, ed., Cold Spring Harbour Laboratory Press (2001)

13.    J. N. Pelletier and S. Sidhu. "Mapping protein-protein interactions with combinatorial biology methods" Curr. Opin. Biotechnol. 12, 340-347 (2001)

12.    L. Jermutus and J. N. Pelletier. "Creating and evaluating protein diversity" Curr. Opin. Biotechnol. 12, 331-333 (2001)

11.    J. N. Pelletier. "A RACHITT for our toolbox" Nature Biotech. 19, 314-315 (2001)

10.    S. W. Michnick, I. Remy, F.-X. Campbell-Valois, A. Vallée-Bélisle and J. N. Pelletier. Detection of protein-protein interactions with protein fragment complementation strategies. Methods in Enzymology, 328, 208-230 (2000)

9.    K. M. Arndt, J. N. Pelletier, K. M. Müller, T. Alber, S. W. Michnick and A. Plückthun. "A heterodimeric coiled-coil pair selected in vivo from a designed library-vs-library ensemble." J. Mol. Biol. 295, 627-639 (2000)

8.    J. N. Pelletier, K.M. Arndt, A. Plückthun and S.W. Michnick. "An in vivo library-vs-library selection of optimized protein-protein interactions." Nature Biotech. 17:683-690 (1999)

7.    J. N. Pelletier, I. Remy and S. W. Michnick. "Protein-fragment complementation assays: A general strategy for in vivo detection of protein-protein interactions." J. Biomol. Tech. 10: 32-40 (1999)

6.    J. N. Pelletier, F.-X. Campbell-Valois and S. W. Michnick. "Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments." Proc. Nat. Acad. Sci. USA 95: 12141-12146 (1998)

5.    J. N. Pelletier and S. W. Michnick. "A Strategy for Detecting Protein-Protein Interactions in vivo Based on Protein Fragment Complementation." Protein Engineering 10 supp: 89 (1997)

4.    M. Allaire, Y. Li, N. Mejia, J. N. Pelletier, R. E. MacKenzie and M. Cygler. "Crystallization of the Bifunctional Methylenetetrahydrofolate Dehydrogenase/ Methenyltetrahydrofolate Cyclohydrolase Domain of the Human Trifunctional Enzyme." Proteins, 26:479-480 (1997)